Delta’s business-class revamp: New seats, menus, plates and more Porsches
Delta is upgrading its top-tier Delta One cabin with new suites for its largest A350 plane, starting next year.
South Texas Latino voters who flipped for Trump in 2024 are up for grabs in 2026
Hispanic and Latino voters swung hard for President Donald Trump in 2024. But in the 2026 midterm election, Democrats are pushing to get them back.
South Texas Latino voters who flipped for Trump in 2024 are up for grabs in 2026
Hispanic and Latino voters swung hard for President Donald Trump in 2024. But in the 2026 midterm election, Democrats are pushing to get them back.
Judge indefinitely blocks Trump from banning 3 media outlets from White House
President Donald Trump had sought to ban media outlets MS NOW, CNN and Politico from reporting from the White House.
Anthropic urges court in Washington, DC, to rehear appeal of Pentagon blacklisting
Anthropic is asking a federal court in Washington, D.C., to rehear its appeal in a case concerning the Pentagon’s blacklisting of the company’s AI models.
Judge says Musk engaged in intimidation of ex-FEMA CFO Mary Comans, clears her name
Ex-FEMA CFO Mary Comans’ name was cleared by a federal judge after Elon Musk and other government officials falsely accused her of criminal actions in 2025.
Airport attacks put aviation in crosshairs of geopolitical conflicts
Deadly attacks at Riyadh’s main airport are disrupting airlines, closing airspace and raising new security questions for commercial aviation.
More Republicans come out against Trump’s diesel deal with Putin
Senators told Trump, the deal with Russian President Vladimir Putin “will not achieve just ends, nor will it benefit Americans.”
Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits
Walmart will offer Novo’s Ozempic and Lilly’s Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.
Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.
